Navigation Links
Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)
Date:12/8/2008

ased in S. Mamede do Coronado, Portugal.

BIAL is strongly committed to therapeutic innovation on research and development every year. This commitment has been recognised in the group's recent integration into the EFPIA (European Federation of Pharmaceutical Industries and Associations), which is dedicated to encouraging research and the development of new therapeutic options.

Key research areas for BIAL are the central nervous system, the cardiovascular system and allergology. BIAL's dedication to research is further demonstrated by the research grants and awards offered by the BIAL Foundation.

Further information about BIAL can be found at http://www.bial.com

References

(1). Zebinix(TM) is one of the proposed EU trade names for eslicarbazepine acetate

(2). Cramer J, Elger C, Halasz P et al. An Evaluation of Quality of Life and Depressive Symptoms During Long-Term Treatment with Eslicarbazepine Acetate: BIA-2093-301 Study.QOL 301. Poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 2009, Seattle, WA, USA.

(3). Soares-da-Silva P, Martins-da-Silva A, Gabbai AA et al. An Evaluation of Quality of Life and Depressive Symptoms During Long-Term Treatment with Eslicarbazepine Acetate: BIA-2093-302 Study. Poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 2009, Seattle, WA, USA.

(4). Pereira H, Lopes-Lima J, Gil-Nagel A et al. An Evaluation of Quality of Life and Depressive Symptoms During Long-Term Treatment with Eslicarbazepine Acetate: BIA-2093-303 Study. Poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 2009, Seattle, WA, USA.

(5). Czapinski P, Halasz P, Elger C et al. An Evaluation of Efficacy and Safety of Eslicarbazepine Acetate (ESL) as Add-on Treatment in Adults with Refractory Partial-Onset
'/>"/>

SOURCE BIAL
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Out beyond the horizon
2. Out beyond the horizon
3. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
4. Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market Dominance
5. Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target
6. WaferGen to Present at the Ninth Annual Beyond Genome Conference
7. Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference
8. Far From Beyond: A Glimpse into the World of Biotechnology and the Future of the Free World
9. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
10. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
11. Probiotic good bugs may control gut infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ov. 19 Omeros Corporatio...cial results for the third quarter ended September..., 2009, Omeros reported a net loss of $3.9 million... $7.4 million, or $2.54 per share, for the same pe...30, 2009, the Company reported a net loss of $15.5...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 ...or in biotechnology for diabetes therapy, and a pr...ices to food, supplement, biotechnology and pharma...previously reported $6.3 million registered direct... shares of its common stock and warrants to purcha...
(Date:11/19/2009)...Md., Nov. 19 Spherix Inc...hnology for diabetes therapy, and a provider of te..., supplement, biotechnology and pharmaceutical com...nnual Meeting of Shareholders. ,, At the meetin...SPEX ) elected the following members to the Board ...
(Date:11/19/2009)...STER, Germany, November 19 MONITOR...ovember 16th, 2009 Flibanserin in the,indication t...arkinson,s,disease for orphan drug status designat...odopa-induced dyskinesia is a complication of the ...erious burden to some of those,affected, since it ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...ho heretofore have not had to worry much about hel...n be asked to add another dimension to their busin...e in the global market. , ,With Wisconsin increas...ace - up 15.1 percent to $17.2 billion in 2006 - a... markets, more technologists will be relied upon t...
...ed businesses to the $1 million annual revenue lev...erhaps none more important than information techno...of the recent Wisconsin Make Mine a Million prog...to leverage information technology to a greater ex..., ,The advice they absorbed from the likes of Laur...
...a partner with the law firm Michael Best & Friedr...e, the firm,s director of government affairs . , ,...t of Energy has announced $200 million in new fin...nding opportunity is open to applicants with proje...development to design, construction, and operation...
Other Biology Technology:Visions: IT exec says CIOs must be ready to help companies ramp up trade 2Visions: IT exec says CIOs must be ready to help companies ramp up trade 3Visions: IT exec says CIOs must be ready to help companies ramp up trade 4Learning from the big boys: With technology, women urged to go gradual 2Learning from the big boys: With technology, women urged to go gradual 3Wisconsin applicants urged to pursue DOE funding for cellulosic biomass 2
(Date:11/19/2009)...tic diversity in maize, also known as corn, resear...ene map that should pave the way to significant im...od, fuel, animal feed and fiber around the world. ...as a haplotype map, charts genetic diversity and r...of maize. The research team, led by U.S. Departmen...
(Date:11/19/2009)...2009 -- Sustainable farming, initially adopted to ...also play a role in maintaining a healthy climate,...rgy,s Oak Ridge and Los Alamos national laboratori... large potential of the earth,s soils to sequester... practices could greatly reduce U.S. carbon emissi...
(Date:11/19/2009)...of maize has identified thousands of diverse genes...e. New techniques may allow breeders and researche...able traits and create new varieties that were not.... 19 issue of Science , the researchers, whose se...ied the first map of haplotypes sets of closely l...
Breaking Biology News(10 mins):ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3New map of variation in maize genetics holds promise for developing new varieties 2Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 1Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 2Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 3With Economic Pain Contributing to Minor Strains and Sprains King Pharmaceuticals Inc and RealAge com Launch Effort to Educate Americans 57809 1With Economic Pain Contributing to Minor Strains and Sprains King Pharmaceuticals Inc and RealAge com Launch Effort to Educate Americans 57809 2With Economic Pain Contributing to Minor Strains and Sprains King Pharmaceuticals Inc and RealAge com Launch Effort to Educate Americans 57809 3With Economic Pain Contributing to Minor Strains and Sprains King Pharmaceuticals Inc and RealAge com Launch Effort to Educate Americans 57809 4With Economic Pain Contributing to Minor Strains and Sprains King Pharmaceuticals Inc and RealAge com Launch Effort to Educate Americans 57809 5With Economic Pain Contributing to Minor Strains and Sprains King Pharmaceuticals Inc and RealAge com Launch Effort to Educate Americans 57809 6Researchers Propose Improved Cervical Cancer Screening 57807 1Researchers Propose Improved Cervical Cancer Screening 57807 2
... U.S. Forest Service Southern Research Station (SR...olly adelgid is killing hemlock trees faster than ...altering the carbon cycle of these forests. SRS re...eorgia published the findings in the most recent i...arks the first time that scientists have tracked t...
...at modern lifestyle habits may play a bigger role ... A review of the scientific evidence over the past...hpaste, good oral hygiene and health education, ma...y. The research is published online in a Supplemen...onty Duggal, an author of the review explained ,No...
...ientists at Georgetown University Medical Center h... looks like when someone anticipates an action or ...ry 25 issue of the Journal of Neuroscience , they...vity in areas of the brain responsible for prepari...ing functional magnetic resonance imaging (fMRI) i...
Other Biology News:Study finds hemlock trees dying rapidly, affecting forest carbon cycle 2Researchers capture wave of brain activity linked to anticipation 2
Anti-SEK1 / MKK4, phospho (Thr261) Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-BACE/Asp2 (CT) Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-Viral WNV Core Polyclonal Antibody, Unconjugated from ProSci, Inc
Anti-Rad51, N-terminal Antibody, Unconjugated from CHEMICON
Biology Products: